Reta glucagon-like peptide-1 (GLP-1) receptor agonists offer a groundbreaking method to diabetes management. These innovative therapies work by mimicking the physiological actions of GLP-1, a hormone released by the gut https://socialeweb.com/story6234931/glp-1-receptor-agonists-as-a-novel-therapy-for-diabetes